The large physician group has a new $55 million facility currently under construction.

Chris Ulvin saved an estimated 9,588 lives over the last six years by organizing blood drives at her church, Christ Our ...

Cellectis (the 'Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

Our Blood Institute (OBI), which encompasses Coffee Memorial Blood Center of Amarillo and other centers in Texas, Oklahoma, ...

BUFFALO — The American Red Cross is encouraging people to give blood amid a slowdown in donations.

Houston's savvy shoppers know the secret. January is the month when closets across the city get a glow-up without wrecking ...

Cellenkos has received orphan drug designation from the US FDA for its investigational CK0804 Treg therapy to treat ...

The city of Tehachapi, Vineyard Church and Houchin Community Blood Bank have announced another year of local blood drives.

NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of John M. Goldberg, MD as fractional Chief Medical Officer (CMO) to advance development of its Large Surface Area ...

Deep hematology/oncology drug development experience added with the appointment of Sherwin Sattarzadeh as Chief Operating Officer and Becker Hewes as Chief Medical Officer ...

Cellenkos® Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf, regulatory T cell (Treg) ...

After finding abnormalities on low-dose CT lung cancer screening, guidelines spell out appropriate follow-up imaging or procedures. A national registry study showed that only 59.7% of patients ...